Enter assignee name

Trademarks = 3

Forward Citations = 36

Loading Chart...

6 inventors (with patents filed for the assignee):

Han-Jie Zhou (7 out of 37 patents)

Peter Virsik (7 out of 21 patents)

Raymond John Andersen (3 out of 43 patents)

4. Marianne Dorothy Sadar (3 out of 18 patents)

5. Kunzhong Jian (2 out of 8 patents)

6. Daniel Andrew Golec (2 out of 2 patents)

7 patents: Sort by Forward Citations

1. 12109179 - Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof (2024-10-08),

2. 11814357 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof (2023-11-14),

3. 11518747 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof (2022-12-06),

4. 11485713 - Androgen receptor modulators and methods for their use (2022-11-01),

5. 11358938 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof (2022-06-14),

6. 11242324 - Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof (2022-02-08),

7. 11059795 - Androgen receptor modulators and methods for their use (2021-07-13),

Essa Pharma, Inc. is a clinical-stage pharmaceutical company focused on the development of novel therapies for the treatment of prostate cancer. The company's lead product candidate, EPI-506, is currently in clinical trials for the treatment of metastatic castration-resistant prostate cancer. Essa Pharma is dedicated to advancing drug development and improving outcomes for patients with prostate cancer.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#134 in Vancouver

#2,094 in Canada

Vancouver, Canada

Essa Pharma, Inc.